Fidelity International’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
– Sell
-45
Closed -$10K – 1067
2020
Q3
$10K Sell
45
-13
-22% -$2.75K ﹤0.01% 750
2020
Q2
$11K Sell
58
-12
-17% -$2.1K ﹤0.01% 729
2020
Q1
$11K Sell
70
-116
-62% -$13.5K ﹤0.01% 700
2019
Q4
$16K Hold
186
– – ﹤0.01% 736
2019
Q3
$13K Hold
186
– – ﹤0.01% 701
2019
Q2
$12K Sell
186
-23
-11% -$1.34K ﹤0.01% 708
2019
Q1
$12K Buy
209
+57
+38% +$3.48K ﹤0.01% 690
2018
Q4
$8K Hold
152
– – ﹤0.01% 717
2018
Q3
$13K Buy
+152
New +$10.8K ﹤0.01% 704

Other funds holding TDOC

Fidelity International's TDOC Position: Q4 2020 in Review

Fidelity International sold out of Teladoc Health (TDOC) in Q4 2020, closing a stake of 45 shares — an estimated $10K sold.

Fidelity International first reported a position in TDOC in Q3 2018 and held it in 9 quarters. The position peaked at $16K in Q4 2019. 901 funds tracked by Wall St. Rank hold TDOC as of Q4 2020.

  • Fidelity International reported no remaining Teladoc Health position as of Q4 2020 after selling out during the quarter.
  • Fidelity International sold 45 Teladoc Health shares in Q4 2020, an estimated $10K.
  • Fidelity International first reported a position in Teladoc Health in Q3 2018 and held it in 9 quarters.
  • Fidelity International's Teladoc Health position peaked at $16K in Q4 2019.
  • 901 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2020.

Based on Fidelity International's 13F filing for Q4 2020, filed 8 Feb 2021.